Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple sclerosis
Biotech
Contineum lowers expectations for $110M IPO
Contineum Therapeutics has lowered its IPO expectations as the J&J-partnered biotech prepares to make the jump to the public markets this morning.
James Waldron
Apr 5, 2024 7:00am
J&J-allied bio files IPO to take fight to BMS, Roche and more
Mar 18, 2024 7:15am
Merck KGaA drops evobrutinib in wake of double phase 3 fail
Mar 7, 2024 9:54am
Kyverna CEO: 'We're in the next phase of medicine'
Feb 9, 2024 1:57pm
Kyverna overshoots raised IPO expectations with $319M offering
Feb 8, 2024 8:24am
After ph. 2 fail, Atara says goodbye to CMO and 25% of staff
Jan 31, 2024 11:22am